v3.26.1
Segment Reporting - Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Loss) (Detail) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Product Revenues        
Product revenues $ 416,166 $ 375,090 $ 809,872 $ 728,944
Significant Segment Expenses and Operating Performance        
Cost of sales 319,739 285,328 616,218 552,717
Net research and development expenses 24,069 22,558 48,015 46,774
Selling, general and administrative expenses 55,705 41,087 111,010 79,565
Restructuring expenses, net 5,964 2,108 12,655 6,622
Loss on sale of land and building, net       2,196
Operating income (loss) 10,689 24,009 21,974 41,070
Other segment disclosures        
Depreciation and amortization 14,523 13,158 28,744 26,089
Operating Segments        
Product Revenues        
Product revenues 416,166 375,090 809,872 728,944
Corporate and Other Unallocated Expenses        
Significant Segment Expenses and Operating Performance        
Other operating expenses 33,956 24,526 69,233 47,694
Other segment disclosures        
Depreciation and amortization 1,320 511 2,489 985
Automotive Segments        
Product Revenues        
Product revenues 404,815 363,852 786,981 705,726
Automotive Segments | Operating Segments        
Product Revenues        
Product revenues 404,815 363,852 786,981 705,726
Significant Segment Expenses and Operating Performance        
Cost of sales 312,691 278,424 603,071 538,651
Net research and development expenses 19,838 17,818 40,719 37,202
Selling, general and administrative expenses 19,443 16,814 36,994 32,533
Restructuring expenses, net 5,651 1,924 11,699 6,438
Loss on sale of land and building, net       2,196
Operating income (loss) 47,192 48,872 94,498 88,706
Other segment disclosures        
Depreciation and amortization 12,335 11,796 24,531 23,398
Medical Segments | Operating Segments        
Product Revenues        
Product revenues 11,351 11,238 22,891 23,218
Significant Segment Expenses and Operating Performance        
Cost of sales 7,048 5,729 13,147 12,005
Restructuring expenses, net 290 156 326 156
Other operating expenses 6,850 5,846 13,035 11,155
Operating income (loss) (2,547) (337) (3,291) 58
Other segment disclosures        
Depreciation and amortization 868 851 1,724 1,706
Corporate Segments | Operating Segments        
Significant Segment Expenses and Operating Performance        
Restructuring expenses, net $ 23 $ 28 $ 630 $ 28